The latest, most relevant reporting on any medical speciality
Dedicated to supporting all healthcare professionals with information that spans a full range of specialties and disease areas
The medwireNews team’s breadth of knowledge spans a full complement of specialties and disease areas, formed over more than 20 years.
Our team of medical writers and journalists has the expertise needed to select the most relevant and topical information within any therapy area, bringing clinical context and valuable insight to the content we provide.
See below for examples of our content by therapy area. Contact us for more information if your therapy area does not feature.
MEET THE SENIOR TEAM
Lucy Piper
medwireNews Bureau Chief
Click links below for recent coverage in diabetes:
- The American Diabetes Association: 82nd Scientific Sessions coverage
- The challenge of type 2 diabetes in children: risk factors and treatment options
- The SURPASS trial results: summarizing efficacy data on tirzepatide, a novel glucose-lowering dual GIP/GLP-1 receptor agonist
- EMPEROR-Preserved: time to reconsider the person with shortness of breath
- Why psychosocial care matters: in recognition of the 25th Anniversary of the EASD’s Psychosocial Aspects of Diabetes study group
Click links below for recent coverage in rheumatology:
- EULAR 2022 Congress: news and expert insights
- Rituximab and rheumatology practice in the COVID-19 era: balancing disease control and infection risk
- JAK inhibitor safety: weighing up the data and understanding the risks
- Safety snapshot: upadacitinib in patients with PsA
- Anifrolumab for the treatment of lupus: results of the TULIP-1 and TULIP-2 trials, approval news, and discussion on lupus trial endpoints
CClick links below for recent coverage in oncology:
- 2022 ASCO Annual Meeting coverage
- NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC
- Early-stage NSCLC management – surgery, targeted treatment and immunotherapy
- COVID-19 and cancer
- 2022 Genitourinary Cancers Symposium coverage
Click links below for recent coverage in haematology:
- ASH 2020 | Risk factors for intracranial hemorrhage in older ITP patients identified
- ASH 2020 | Rilzabrutinib achieves ‘durable response’ for heavily pretreated ITP patients
- ASH 2020 | ROCKstar: Belumosudil shows potential for refractory, advanced GvHD
- ASH 2020 | ASCEMBL findings support STAMP inhibitor for heavily pretreated CML
- ASH 2020 | FLIGHT trial: Mycophenolate plus steroid a possible first-line option for ITP
Click links below for recent coverage in neurology:
- Night-time apomorphine improves sleep disturbances in people with Parkinson’s disease
- TREM2 may have protective effect in Alzheimer’s disease
- Serum NfL could serve as a biomarker in spinocerebellar ataxia type 1
- BDNF Val66Met modifies outcomes in dominantly inherited Alzheimer’s disease
- SUNFISH shows efficacy of risdiplam in patients with spinal muscular atrophy
Click links below for recent coverage in endocrinology:
- Research focus – New genetic insights into early-onset severe obesity
- Logistic issues hinder transition from paediatric to adult endocrine care
- No influence of age on burosumab response in X-linked hypophosphatemia
- Weekly somatrogon noninferior to daily somatropin in paediatric GHD
- Increased peak GH response with oral GH secretagogue receptor agonist in children with GHD
